Upsala J Med Sci 92: 115-146, 1987 The Complete Amino Acid Sequence of Human Serum Retinol-binding Protein Lars Rask', Helena Anundi', Jan Fohlman3 and Per A. Peterson4 Department of Cell Research, University of Uppsala and Swedish University of Agricultural Sciences, Uppsala, Sweden ABSTRACT The complete amino acid sequence of human serum Retinol-binding protein (RBP) including the distribution of its three disulfide bridges, has been determined. The protein consists of 1 8 2 amino acid residues, the order of which was determined following the isolation of five CNBr-fragments. Direct amino acid sequence analysis in an automatic liquid phase sequencer provided almost the entire sequences of the five CNBr-fragments. Several sets of enzymatically derived peptides of RBP were also used to elucidate the.primary structure. RBP displays significant homology to bovine P-lactoglobulin, human al-microglobulin and rat al-microglobulin. RBP contains an internal homology. Thus, residues 36 to 83 display statistically significant homology with residues 9 6 to 1 4 1 . INTRODUCTION From its site of synthesis in the liver ( 2 8 , 3 6 , 4 8 ) the Retinol-binding protein (RBP)' carries one molecule of retinol ( 2 0 , 3 3 , 3 4 ) to vitamin A requiring cells. While transporting retinol in plasma, RBP forms a stable complex with thyroxine-binding prealbumin ( 2 0 , 3 3 ) . This complex formation prevents RBP, which has a molecular weight of 21 000, to pass the kidney glomeruli ( 3 4 ) . Cells requiring vitamin A express a receptor for RBP on their cell membranes ( 1 9 , 4 1 1 . On recognizing RBP the receptor takes up the vitamin. Simultaneously, RBP undergoes a conformational change, the nature of which is presently unknown. This conformational change does not allow a sustained binding between RBP and prealbumin ( 1 9 , 4 3 1 . Due to the abolished protein-protein interaction the free RBP molecule becomes degraded in the 'Abbreviations used are: RBP - Retinol-binding protein dansyl - 1-dimethyl-aminoaphthalene-5-sulphonyl chloride EDTA - ethylenediaminotetraacetate CM-cysteine - carboxymethylcysteine cys-A - cysteic acid 8-878572 115 kidney following glomerular filtration and reabsorption in the tubuli cells (34). To understand how RBP interacts with retinol, prealbumin and the cell- surface receptor and how these interactions may become modulated, it appeared of importance to establish the amino acid sequence of RBP. The primary struc- ture of RBP was also a prerequisite for the interpretation of high-resolu- tion X-ray crystallographic data. In this communication we describe the complete amino acid sequence of human RBP. Part of this information has appeared in preliminary form (40). A partial primary structure of human RBP has also been reported by Kanda and Goodman ( 2 1 ) . Recently, a cDNA clone encoding human RBP has been analysed ( 5 ) . MATERIALS AND METHODS Isolation of RBP - The RBP used in the sequence studies was isolated from human serum (34) and urine (35). The purity of the RBP preparations was assessed as described (34,351. Peptide nomenclature - The peptides obtained after cyanogen bromide cleavage are designated A . B, and C followed in some instances of a number and a letter, indicating the order of emergence of a particular peptide during fractionation. H denotes a peptide obtained after acid cleavage. Peptides isolated after digestion of RBP by trypsin, chymotrypsin, thermolysin, and clostripain are symbolized by R, RC, RT and C1, respectively. Peptides obtained from CNBr-fragment A3b after digestion with clostripain are designated A3b and those from tryptic and chymotryptic digestions of CNBr fragment C, C and CT, respectively. Peptides isolated from CNBr fragment A1 after digestion with Staphylococcus aureus protease V 8 are called SA SB, with chymotrypsin AC, with thermolysin AT, with pepsin AP, with subtilisin AS and with clostripain AC1, respectively. Peptides obtained after cleavage of unreduced RBP with acid, trypsin and pepsin are denoted S, T and P, respectively. The numbers that follow the symbols indicate the order of emergence of a particular peptide during fractionation. Reduction, alkylation, CNBr-fragmention and acid cleavage - These procedures were carried out as described (51). Enzymatic digestion of RBP and RBP fragments - Trypsin digestions were performed on samples (0.1 to 3 pmoles) in 0.2 M NH4HC03, pH 8.0, at protein to enzyme ratios of 1OO:l to 5 0 : l . The protein or peptide concentration was usually between 5 and 10 mgfml. Digestions were carried out at 37O for 3 hours and were terminated by lyophilization. a-Chymotrypsin and subtilisin digestions were performed similarly. Also thermolysin digestions were and 116 conducted in the same fashion but the buffer was 0 . 2 M NH4HCO3, pH 8.0, containing 5 mM CaC12 and the reaction was terminated after 2 Pepsin digestions were carried out at an enzyme to substrate ratio of 1:50 (w/w) at 37O for 3 hours in 5% (v/v) formic acid. Digestions with clostripain were performed at pH 7.8 in 0.1 M NH4HC03. containing 2 mM DTT and 1 mM CaC12. After 2 to 3 hours at 37O the reaction mixture was lyophilized. The substrate to enzyme ratio was 5O:l. Staphylococcus aureus protease V8 was used at a protein to enzyme ratio of 50:l. The substrate was dissolved in 0.2 M NH4HC03, pH 8.0, containing 1 mM EDTA and after 2 hours at 37O the digestion mixture was lyophilized. hours. To investigate the distribution of the disulfide bridges of RBP, the CNBr- fragments Al, A2, A3a and A3b, which were held together by disulfide bonds (fraction A of Fig. lA), were digested with trypsin and pepsin. The CNBr- fragment mixture, at a concentration of about 10 mg/ml in 0.2 M Tris-acetate buffer, pH 6 . 0 , was digested for 8 hours at 37O with trypsin at an enzyme to substrate ratio of 1:50. The same amount of CNBr-fragments in 0.2 M sodium acetate buffer, pH 5.0, was digested with pepsin (final concentration 0.2 mg/ml) for 8 hours at 37O. Carboxypeptidase A and B digestions were carried out as described (51). Peptide fractionation - Large peptides of RBP were usually separated by gel chromatography on columns of Sephadex G - 1 0 0 and G - 5 0 equilibrated with 0.05 M sodium acetate buffer, pH 5.0, containing 6M guanidine-HC1 or with 10% propanol - 0.025% ammonia in water. Smaller peptides were purified by high voltage electrophoresis in pyridine-acetate buffer, pH 6.5 (pyridine:acetic acid:water, 100:3:897 v/v) and pH 3.5 (pyridine:acetic acid:water, 1:10:189 v/v). The electrophoreses were carried out on 60 to 100 cm long Whatman No 3MM papers at 40 V/cm for 60 to 100 min. Further purification of impure peptide fractions was accomplished by descending paper chromatography developed with butano1:acetic acid:water:pyridine (15:3:12:10 v/v). Localization of peptides was accomplished by staining the papers with fluorescamine. Purified peptides were eluted from papers with 0.1% ammonia. Some peptides were purified by ion exchange chromotography on DEAE- Sepharose columns equilibrated with 0.02 M NH4HC03. The applied sample was usually eluted with a 250 ml linear gradient of NH4HC03 from 0.02 to 0.2 M. The occurrence of peptides in the effluent was monitored by measuring the absorbance at 2 2 0 nm or at 280 nm. Occasionally aliquots were withdrawn for ninhydrin analysis (see below). Peptide digests were also separated on a modified JEOL-5 AH amino acid analyzer (18). The column (11~0.5 cm), maintained at a temperature of 50°, 117 contained the JEOL type AR-15 sulfonated resin. The applied material, usually between 15 and 30 mg of peptide mixture, was eluted as described (18). The flow rate was 1.85 ml/min and fractions of 3.0 ml were collected. For the separation of some peptides advantage was taken of column zone electrophoresis (37). The column (86x1 cm), packed with water-pyridine-extracted cellulose and cooled by running water, was equilibrated with a pH 1.9 buffer composed of acetic acid:formic acid:water (78:25:897 v/v). After application the samples were usually displaced downward to an appropriate starting point and runs were conducted at 1000 V for 8 to 12 hours. After electrophoresis the column, which had a total free liquid volume of about 60 ml, was eluted at a flow rate of 12 ml/hour (13). High pressure liquid chromatography was also used to purify some peptides. Two model llOA pumps (Altex, Berkley, California), an Altex model 400 solvent programmer and a micro-Bondapak c18 column (300x3.9mm, Waters Associates Inc., Milford, Mass.) were used. The column was equilibrated with 2 mM ammonia adjusted to pH 2 . 4 with trifluoroacetic acid and 5% methanol. Elution was accomplished with a linear gradient of methanol from 5% to 55% followed by 30 ml of 55% methanol in the ammonia trifluroacetic acid buffer. Peptides in the effluent were detected by measuring the absorbance at 206 nm. The flow rate was 24 ml/h and fractions of 0 . 4 ml were collected. Alkaline hydrolysis and ninhydrin analysis - For alkaline hydrolysis appropriate aliquots were evaporated to dryness at 110'. 0.5 ml of 2.5 M NaOH was added. The hydrolysis was carried out at llOo for 3 hours. Following neutralization with 1.0 ml of 1.5 M acetic acid, 1.0 ml of the ninhydrin reagent was added. After 15 min in a boiling water bath each fraction was diluted with 2 ml of 50% ethanol and the absorbance at 570 nm was estimated.. Amino acid analyses - Amino acid analyses were carried out as described (51). Amino acid sequence determinations - Automatic amino acid sequence determinations were carried out as described (51). Amino acid sequence determinations were also accomplished with the dansyl end group method in conjunction with the Edman technique (17). Dansyl amino acids were identified by two-dimensional chromatography on 5x5 cm polyamide thin layer sheets. The solvent systems used were those of Woods and Wang (56). Statistical analyses for relatedness of RBP sequence to other proteins -The RBP sequence was compared to a data file containing sequences of other proteins ( 6 - 9 ) , with the SEARCH program (9). The program ALIGN ( 2 9 ) was used to analyse the alignment of homologous sequences. The matrix bias parameter and the break penalty parameter were set to 2 and 6, respectively. These values are appropriate when comparisons are made between distantly related sequences. 118 RESULTS Isolation and NH2-Terminal Amino Acid Sequence Determination of Human RBP CNBr-Fragments -RBP was cleaved with CNBr and the resulting fragments purified by repeated gel chromatographies (Fig. 1 and 2). The amino acid compositions and the yields of the fragments are summarized in Table 1. Since human RBP contains four methionines (43) five CNBr-fragments were expected. However, six fragments were isolated (Table 1). This result together with the observations that the amino acid composition of fragment A2 is almost identical to the combined composition of fragments B and A3b, that A2 contains more homoserine residues than anyone of the other fragments and that the yields of fragments A2, B and A3b vary somewhat from preparation to preparation, strongly suggested that fragment A2 was a product of incomplete CNBr-cleavage. Fragment A1 was the only one lacking homoserine (Table 1). Fig. 1. Gel Chromatography on a column (142~1.5 cm) 0 w ;'Ol of Sephadex-G-iO0 equilibrated with 0.05 M sodium acetate buffer, pH 5.0, containing 6M guanidine-HC1. A . The sample, 80 mg of CNBr-cleaved RBP, was eluted at a flow rate of 4 ml/h and fractions of 1.5 ml were collected. The bars denote materials which were pooled, desalted and lyophilized. B. Fraction A Fig. 1. A was dissolved in 3 ml of 1 M Tris-C1 buffer,pH 8.0, containing 6 M guanidine-HC1 and 50 mM EDTA. After the addition of dithiothreitol to a final concentration of 10 mM the sample was incubated for 30 min at room temperature. Iodoacetic acid to a final concentration of 25mM was then added and after another 15 min in the dark the sample was exhaustively dialyzed against the equilibrating buffer of the column. The sample was then chromatographed on the Sephadex G-100 column under conditions identical to those described above. 'The bars denote materials which were use6 in subsequent analyses. Fig. 2. Gel chromatography on a column (125 x 1.5 cm) of Sephadex G-50 equilibrated with 0.05 M sodium acetate buffer, pH 5.0, containing 6 M guanidine-HC1. The material subjected to fractionation was fraction A3 of Fig. 1B. The column was operated with a flow rate of 6 ml/h and 1.5 ml fractions were collected. Material denoted by bars were pooled, desalted and lyophilized. 119 Table 1. Amino acid compositions of cyanogen bromide fragments of human RBPa The integral values in parantheses are based on the sequence. CNBr-A1 CNBr-A2 CNBr-A3a CNBr-A3b CNBr-B CNBr-C RBP" Residue 89-182 28-73 1-27 54-73 28-53 74-88 1-182 Lysine 3.41(3) 2.75(3) 2.00(2) l.OO(1) 1.86(2) 1.82(2) 10.19(10) Histidine 1.88(2) 0.26 2.00(2) Ar g in ine 7.88(8) 2.36(2) 3.68(4) 2.09(2) 0.30 14.02(14) CM-Cysteine 4.12(4) 1.33(1) 1.21(1) 0.72(1) 4.91(6) Aspartic acid 14.01(14) 6.90(8) 3.36(3) 3.54(4) 4.00(4) 2.00(2) 26.03(27) Threonineb 3.45(3) 1.90(2) 1.13(1) 0.95(1) 1.25(1) 2.60(3) 9.35(9) Ser ineb 5.67(6) 2.65(2) 3.15(3) 1.23(1) 1.35(1) 0.38 10.89(11) Homoserine 0.05 0.56(2) 0.39(1) 0.42(1) 0.40(1) 0.48(1) Glutamic acid 10.30(10) 5.94(5) 2.30(2) 0.43 4.38(5) 1.41(1) 18.28(18) Proline 3.36(3) 1.36(1) 1.10(1) 1.18(1) 6.84(5) Glycine 6.23(6) 2.87(3) 1.17(1) 1.20(1) 2.00(1) 1.41(1) 11.21(11) Alanine 5.35(5) 4.08(5) 2.36(2) 2.57(3) 2.01(2) 1.12(1) 13.90(13) ValineC 5.95(6) 3.69(4) 2.05(2) 1.97(2) 1.89(2) l.OO(1) 12.20(13) Methionine 3.84(4) IsoleucineC 3.07( 3) 0.78( 1) 0.68(1) 3.96(4) Leucine 9.00(9) 3.89(4) 1.65(2) 1.95(2) 0.36 12.78)13) Tyrosine 6.75(7) 0.41 0.93(1) 0.37 8.06(8) Phenylalanine 3.29(3) 2.24(2) 2.64(3) 0.34 1.81(2) 1.80(2) 10.14(10) Tryptophan 1.48(2) 0.61(1) 0.67(1) 0.71(1) 5.22(4) Yieldf ( X ) 80 40 82 45 40 85 aExcept where noted all figures are average values of one 24 h and one 72 bValues obtained by extrapolation to 0 h hydrolysis. '72 h hydrolysis value. dData taken from ref. 40. eDetermined spectrophotometrically. fThese data are based on one preparation from 6pmoles of RBP. Other prepara- hydrolysis tions gave similar values although the yields of fragments A2, A3b and B somewhat v a r i e d . Intact, reduced and carboxymethylated RBP and the six CNBr-fragments were separately subjected to NH2-terminal amino acid sequence determination in an automatic liquid phase sequencer. By this procedure almost the entire primary structure of fragments A3a, B, A3b and C could be elucidated (Table 2 and Fig. 3). The NH2-terminal amino acid sequences of fragments A2 and B were identical confirming that fragment A2 is the result of incomplete CNBr- cleavage of RBP. The NH2-terminal amino acid sequence of intact RBP provided unambiguous information for 40 residues (Table 2 and Fig. 3). This information was sufficient to establish that fragment A3a is the NH2-terminal CNBr-fragment and that it is followed by fragment B(A2) in the sequence. Alignment of the CNBr-fragments of human RBP - In order to establish the order of the CNBr-fragments of RBP the intact protein was digested separately with several enzymes and during fractionation methionine-containing peptides were particularly looked for. During the course of this work a number of other 120 peptides were also obtained, some of which were important for establishing the primary structure of RBP. Thus, in this section such peptides will also be described. Reduced and carboxymethylated RBP was digested with trypsin, chymotrypsin and thermolysin, respectively. After lyophilization each digest was separately subjected to gel chromatography on a column of Sephadex G-25 (Fig. 4 ) . NH2- terminal amino acid sequence determinations demonstrated that all peptide fractions obtained were impure. Further purification was accomplished by combining high-voltage paper electrophoresis with paper chromatography. The amino acid compositions, the purification procedure and the amino acid sequence of each peptide are presented in Table 3A. Peptides R5, R10, RC2, RC3, RC8 and RT1 contained methionine residues. The amino acid sequences of peptides R5, R10 and RC2 (Table 3B) established that CNBr-fragments A3a and B were juxtaposed (see above). Peptide RT1 connected CNBr-fragments B and A3b. Since CNBr-fragment A 1 lacked homoserine it had to be the COOH-terminal fragment. Consequently, the only remaining fragment, C, had to be positioned in between fragments A3b and Al. This notion was supported by the observation that peptide RC8 connected C with A1 (Table 3). Further support for the order of the CNBr-fragments was obtained from analyses of two other peptides. After cleavage of intact, reduced and carboxymethylated RBP with clostripain, two peptides were isolated following gel chromatography on a column of Sephadex G-100 (Fig.5). After rechromatography on the same column of the peaks denoted C1 I and C1 I1 (Fig. 5B and C) amino acid analyses demonstrated that C1 I comprised 59 and C1 I1 41 amino acid residues (Table 4 ) . NH2-terminal amino acid sequence determination in the automatic sequencer of fragment C1 I provided almost its entire structure (Table 4). This result definitely showed that CNBr-fragment A3a was followed by B and A3b. The NH2-terminal 15 residues of fragment C1 I were determined (Table 4 ) which connected fragment A3b with C. Thus, the order of the CNBr-fragments of RBP is A3a-B-A3b-C-A1. CNBr-fragment A2 occurs as a consequence of the incomplete cleavage of the Met-Ser bond joining CNBr- fragment B with A3b (see Fig. 6). Fig. 3. (Next page) The yields of PTH-amino acids in each degradation cycle. The materials subjected to amino acid sequence determination contained A) intact, reduced and alkylated RBP; 120 nmoles. B ) CNBr-fragment A3a; 90 nmoles. C) CNBr- fragment A2; 210 nmoles. D ) CNBr-fragment B; 110 nmoles. E ) CNBr-fragment A3b; 80 nmoles. F) CNBr-fragment C; 120 nmo1es.G) CNBr-fragment Al; 240 nmoles and H ) acid cleavage fragment H-2; 220 nmoles. The initial yields, which in the figure are normalized to 100% were A) 7 4 nmoles. B) 52 nmoles. C ) 130 nmoles. D ) 61 nmoles. E) 49 nmoles. F) 67 nmoles. G ) 138 nmoles and H) 113 nmoles, respectively. 121 -1 * w 1 I I I (3 E -- 0 0 0 BoD.oBB,, t o o - - ' 0 % O c a o 0 a0 o o o o O 0 : o 08, 50 - 0 B O O O o o a 00 0 -_ 0 0 8 0 10- 0 00,". oo 0 O 0 0 QJ 0 0 2 - I 8 1 d I 1 I I .- H 0 0 0 0 0 0 %o 0 - 00 0 0 0 0 soo 0 _ _ 0 oo ,-o" 0 *O% I I Table 2. NH2-terminal amino acid sequence determination of CNBr-fragments of RBP (A) and of intact RBP (B). Material Amino acid sequence A . A1 Lys-Tyr-Trp-Gly-Val-Ala-Ser-Phe-Leu-Gln-Lys-Gly-Asn- -Asp-Asp-His-Trp-Ile-Val-Asp-Thr-Asp-Tyr-Asp-Thr-Tyr- -Ala-Val-Gln-Tyr-Ser-CMCys-Arg-Leu-Leu-Asn-Leu-Asp- -Gly-Thr-CMCys-Ala-Asp-Ser-Tyr-Ser-Phe-Val- -1le-Val-Ala-Glu-Phe-Ser-Val-Asp-Glu-Thr-Gly-Gln- A2 Ala-Lys-Lys-Asp-Pro-Glu-Gly-Leu-Phe-Leu-Gln-Asp-Asn- A3a Glu-Arg-Asp-CMCys-Arg-Val-Ser-Ser-Phe-Arg-Val-Lys-Glu- -Am-Phe-Asp-Lys-Ala-Arg-Phe-Ser-Gly-Thr- A3b Ser-Ala-Thr-Ala-Lys-Gly-Arg-Val-Arg-Leu-Leu-Asn-Asn- -Trp-Asp-Val-CMCys- B Ala-Lys-Lys-Asp-Pro-Glu-Gly-Leu-Phe-Leu-Gln-Asp-Asn- -1le-Val-Ala-Glu-Phe-Ser-Val-Asp-Glu-Thr-Gly- C Val-Gly-Thr-Phe-Thr-Asp-Thr-Glu-Asp-Pro-Ala-Lys-Phe- - B. RBP Glu-Arg-Asp-CMCys-Arg-Val-Ser-Ser-Phe-Arg-Val-Lys-Glu- -Asn-Phe-Asp-Lys-Ala-Arg-Phe-Ser-Gly-Thr-Trp-Tyr-Ala- -Met-Ala-Lys-Lys-Asp-Pro-Glu-Gly-Leu-Phe-Leu-Gln-Asp- 122 20 10 20 s 0 N 2 10 W z P 2, 10 C n 100 200 EFFLUENT VOLUME (mi) EFFLUENT VOLUME ( m l ) Fig. 4 . Gel chromatography of tryptic (A), chymotryptic (B) and thermolytic (C) digests of RBP. In each case 2 p m o l e s of reduced and carboxy- methylated RBP were digested. The columns (152~1.5~111) of Sephadex G-25 were equilibrated with 0.025% ammonia and 10% n-propanol in water. Fractions of 2.0 ml were collected at 10-min intervals. The bars indicate fractions pooled and lyophilized. The peptides have the same designations as in Table 3. Fig. 5. Gel chromatography on a column (175~1.2 cm) of Sephadex G-100 equilibrated with 0.05 M sodium acetate buffer, pH 5.0, containing 6 M guanidine-HC1 of a clostripain digest of 3 . 1 p m o l e s of carboxy- methylated RBP (A). Fractions denoted by the bars (C1 I and C1 11) in A were pooled, desalted, lyophilized and resub- jected to the same Sephadex G-100 column (B and .C). The flow rate of the column was 2.8 ml/h and fractions were collected every 25 min. Fractions denoted by the bars in B and C were pooled, desalted and subjected to amino acid analysis and sequential degradation. The complete Amino Acid Sequence of CNBr-Fragment A3a -The complete amino acid sequence of CNBr-fragment A3a was obtained by automatic amino acid sequence determination of intact RBP (Table 2B). This sequence was corroborated by direct automatic sequencing of fragment A3a (Table 2A), which 123 provided information for 23 out o f the 27 residues. Additional information was obtained from the amino acid sequences of peptides R3, R4, R6, R10, RC2, RC4, RC6, RC7, RT5 (Table 3) and clostripain fragment C1 I1 (Table 4) as summarized in Fig. 6. Table 3. Amino acid compositiona and amino acid sequenceb of some tryptic, chymotryptic and thermolytic peptides of carboxy- methylated RBP Pep- Pur i - tide f ica- De - Amino Acid Composition Yield' t ion' sig- Pro- na- ce- t ion dure A _ - Trypt ic R1 R2 R3 R4 R5 R6 R7 R8 R9 R10 K0.8D2.2E1. 8P3.0G1.0A1. lL1 .2 C0.9D3.0T0.9S0.8G1 .OA1. lL3.OY0.9 K2. OD2. lE1. 1'0. 8F1. 0 R2. OcO. 8D1. OEO. 7 K2. 4A2. OMO. 9 R 1 . 3% .9'0. gF1. 0 R1. OGO. 7 K1 .4T0.9S1.0G1 .0A1.8M0.9Y0. 8F1 .O R1. OVO. 9 Kl.OF1.0 Chymotryptjc RC 1 Kl. 7D0.9E1. lP1 .0G1.0A0.9L0.9F0.9 RC2 K2,3D1. 1E1.0P1.3G1.4A2. lM1 .OF1.O RC 3 D1.3T1 .2s0. gE2.0G1 . O v l .2M0.8 RC4 R2.0C0. 7D0.9S1. 7E1.4V1 .0F0.9 RC5 R0.7K1.2T1 .OSO.gG1. lA1 .gV1. 1 RC6 K1. 2R1 .2D0. 7A0. 8F0. 8 RC8 K2. OMO. gY1* Thermolytic RT 1 RT2 RT3 D1. 8E1. OLO. 8 RT4 OAO. 8'0. 4'0.4 RT5 K O . 8D1. O E 1 . 2'0.8 RC 7 K i . 3R1.3Do. 9%. 9'1. a F i .I D1. 2T1 . O s l .0E2. lG1. lVl.OM0.8 K0.9D1.9T1. 7E1. lP1 .OA1 .0F0.8 moles 184 385 231 180 92 274 233 319 57 75 233 114 435 87 55 473 194 35 48 356 215 200 293 z 9.2 19.5 11.7 9.1 4.6 13.7 11.7 16.0 2.9 3.7 11.7 3.8 21.7 4.3 2.8 23.7 9.7 1.8 2.4 17.8 10.8 10.0 14.7 residue AB 140-150 AB 122-133 ABD 11-17 ABC 1-5 AB 26-30 AB 6-10 ABD 61-62 AB 59-60 AB 86-87 AB 20-29 ABCD 28-36 ABCD 26-36 ABC 46-53 ABD 1-9 AB 54-61 ABDC 16-20 ABDC 10-15 AB 87-90 ABD 47-54 ABD 77-85 ABC 37-40 ABC 41-44 ABD 11-14 Amino Acid Sequence E- Tryptic R1 Asx-Pro-Asx-Gly-Leu-Pro-Pro-Glx-Ala-Glx- R2 Leu-Leu-Asx-Leu-Asx-Gly-Thr-CMCys-Ala- R3 Val-Lys-Glx-Asx-Phe-Asx- R4 Glx-Arg-Asx-CMCys-Arg R5 Ala-Met-Ala-Lys- R6 Val-Ser-Ser-Phe-Arg R7 Val-Arg R8 Gly-Arg R9 Phe-Lys R10 Phe-Ser-Gly-Thr-(-)-Tyr-Ala-Met 124 Chymotryptic RC1 Ala-Lys-Lys-Asx-Pro-Glx-Gly-Leu-Phe RC2 Ala-Met-Ala-Lys-Lys-Asx-Pro-Glx-Gly-Leu-Phe RC3 Ser-Val-Asx-Glx-Thr-Gly-Glx-Met RC4 Glx-Arg-Asx-CMCys-Arg-Val-Ser-Ser-Phe RC5 Ser-Ala-Thr-Ala-Lys-Gly- RC6 Asx-Lys-Ala-Arg-Phe RC7 Arg-Val-Lys-Glx-Asx-Phe RC8 Lys-Met-Lys-Tyr Thermolytic RT1 Val-Asx-Glx-Thr-Glv-Glx-Met-Ser RT2 Phe-Thr-Asx-Thr-Glk-Asx-Pro-Ala- RT3 Leu-Glx-Asx-Asx RT4 Ile-Val-Ala-Glx RT5 Val-Lys-Glx-Asx a) b) c) d) The letters have the following meaning: A, gel chromatography All analyses are 24h hydrolysis values. All sequence analyses were carried out by the dansyl-Edman technique. Yields are not corrected for material taken for analyses during the course of the purification procedure. on Sephadex G-25; B, high voltage paper electrophoresis at pH6.5; C, high voltage paper electrophoresis at pH 3 . 5 ; D, paper chroma- Table 4A. Amino acid composition of two clostripain peptides obtained from carboxymethylated RBPa Amino c1 I residue 63-121 C1 I1 residue 20-60 Acid Found To Sequencea Found To Sequenced nearest nearest integer integer molelmo le mole/mole Lysine 3.8 4 4 2.7 3 3 Histidine 1.0 1 1 0.3 Arginine 1.3 1 1 1.2 1 1 CM-cysteine 1.7 2 2 0.1 Aspart ic acid 10.7 11 12 4.1 4 4 Threonineb 4.4 4 5 2.7 3 3 Serineb 2.0 2 2 3.3 3 3 Glutamic acid 3.1 3 3 5.1 5 5 Proline 1.4 1 1 1.0 1 1 Glycine 3.4 3 3 3.7 4 4 Alanine 4.0 4 4 4.8 5 5 Valine' 4.6 5 5 2.1 2 2 Methionine 1.6 2 2 1.6 2 2 IsoleucineC 1.3 1 1 1.0 1 1 Leucine 3.4 3 3 2.0 2 2 Tyrosine 3.4 3 4 1.0 1 1 Phenyl- alanine 2.8 3 3 2.8 3 3 Tryptophan 2.6 3 3 0.6 1 1 Yield ( X ) 45 68 aExcept where noted all figures are average values of one 24 h and one bValues obtained by extrapolation to 0 h hydrolysis. c72 h hydrolysis value. dCalculated from Fig. 6. 72 h hydrolysis. 125 Table 4B. Amino acid sequence of clostripain fragments C1I and ClII. Peptide Designation Amino Acid Sequence c1 I Leu-Leu-Asn-Asn-Trp-Asp-Val-CMCys-Ala-Asp-Met-Val-Gly- Thr -Phe- c1 I1 Phe-Ser-Gly-Thr-Trp-Tyr-Ala-Met-Ala-Lys-Lys-Asp-Pro-Glu- Gly-Leu-Phe-Leu-Gln-Asp-Asn-Ile-Val-Ala-Glu-Phe-Ser-Val Asp-Glu-Thr-Gly-Gln-Met-Ser-Ala-Thr-Ala- aFor both peptides 120 nanomoles were subjected to automatic sequence determination in the liquid phase sequencer. The repetetive yield for C1 I1 was 92% and for C1 184%. Fig. 6. Amino acid sequences of peptides used to estab- lish the primary struc- ture of RBP. For desig- nations of peptides, see text. j denotes NHZ-terminal amino acid sequencing by means of liquid phase sequencer or by the manual dansyl-Edman procedure. -denotes amino acid residues released after carboxypeptidase diges- tion as quantitated by amino acid analysis. The complete Amino Acid Sequence of CNBr-fragment B - Thirteen out of the 26 amino acid residues of CNBr-fragment B were obtained by automatic amino acid sequence analysis of intact RBP (Table 2B). By the same procedure fragments B and A2 provided 24 and 25 residues, respectively. Corroborative information was obtained from peptides R10, RC1, RC2, RC3, RT1, RT3, RT4 (Table 3) and CI I1 (Table 4). The Complete Amino Acid Sequence of CNBr-fragment A3b - Automatic amino acid sequence analysis of CNBr-fragment A2b provided information for 17 out of the 20 positions (Table 2A). Clostripain .eptide C1 I1 (Table 4) corroborated the NH2-terminal sequence of the fragment and peptide C1 I (Table 4) established Other peptides like R7, R8 and RC5 (Table 3) supported the established sequence. However, since the amino acid sequence of the COOH-terminal half of fragment A3b relied only on the COOH-terminal region of A3b (Fig.6). 126 analyses performed on rather large peptides, A3b was digested with clostripain. The peptide mixture was fractionated by DEAE-Sepharose ion exchange chromatography. Three peptides were obtained (Fig. 7). The combined amino acid composition of peptides A3b1, A3b2 and A3b3 was identical to that of fragment A3b (Table 5) and with the amino acid sequence of the three peptides (Table 5) the sequence of CNBr-fragment A3b (Fig.6) was ascertained. The complete Amino Acid Sequence of CNBr-frament C - The amino acid sequence of the CNBr-fragment C, comprised of 15 amino acid residues (Table l), was elucidated by automatic sequencing of the intact fragment, which yielded information in 13 positions (Table 21, and by sequence analysis of peptides R9and RC8 (Table 3). Corroborative information was obtained from peptide C1 I (Table 4) and from tryptic and chymotryptic peptides of fragment C. These peptides, C1, C2, CT1 and CT2 were isolated by high voltage paper electrophoresis and paper chromatography (Table 4) and their sequences established the primary structure of CNBr-fragment C (Table 6 and Fig. 6). Table 5. Amino acid composition and amino acid sequence of clostripain peptides derived from 0.8 pole of CNBr-fragment A3b Peptide Designation Amino Acid Compositiona Yield Residue nmoles 1 40 54-60 36 61-62 A3b2 R1.O vo.9 290 A3b3 c0.9 D3.6 A1.l vl.O M0.9bL1.6 380 48 63-73 A. A3bl K1.O R0.9 T0.9 so.9 G1.2 A1.9 320 Amino Acid Sequence' B. A3bl Ser-Ala-Thr-Ala-Lys-Gly-Arg A3b2 Val-Arg A3b3 Leu-Leu-Asn-Asn-Trp-Asp-Val-CMCys-Ala aThe amino compositions are based on 24 hydrolysis values only. bDetermined as homoserine . CFor A3bl (68 nanomoles) and A3b3 (82 nanomoles) sequence determination was accomplished in an automatic liquid sequencer. Peptide A3b2 (32 nanomoles) was analyzed by the manual dansyl- Edman technique. The Complete Amino Acid Sequence of CNBr-fragment A1 - CNBr-fragment A1 repre- sents more than half of RBP. Automatic sequencing of the entire Al- fragment provided information for 48 out of its 94 residues (Table 2). Since 127 100 200 EFFLUENT VOLUME tml) Fig. 7. DEAE-Sepharose ion exchange chromatography of a clostri- pain digest of 0.8 pmoles of CNBr-fragment A3b. The column (12x1 cm) was equilibrated with 0.02 M NH4HC03. The applied sample was eluted with a 250 ml linear gradient of NH4HC03 from 0.02 to 0.2 M. The flow rate was 18ml/h and fractions of 2 ml were collected. The bars indicate material pooled, lyophilized and used in further analyses. preliminary studies had shown that CNBr-fragment A1 contained a single aspartyl-prolyl bond, which is sensitive to acid proteolysis (23), fragment A1 was cleaved with formic acid. Two fragments of similar size, Table 6 . Amino acid composition and amino acid sequence of tryptic and chymotryptic peptides obtained from CNBr fragment Ca Peptide Puri- Designa- Amino Acid Compositionb Yield fication Residue t ion Proce- A nmoles 5 74-85 I -&.? E1.2 p1.2 G1.O 190 9-5 Tryptic c1 K0.9 D1.e T? . B D c2 K1.O M0.6dFl.l 280 14 B 86-88 B 74-82 CT2 K1.8 M0.5dP0.9 A1.2 F1.O 150 7.5 B 83-88 CT1 D2.1 T2.8 E1.O G1.l vl.O F0.9 lg0 A1.O VO.8 ro.9 Chymotryptic Amino Acid Sequencee B. Tryptic C1 Val-Gly-Thr-Phe-Thr-Asx-Thr-Glx-Asx- C2 Phe-Lys- CT1 Val-Gly-Thr-Phe-Thr-Asx-Thr-Glx-Asx CT2 Pro-Ala-Lys-Phe-Lys- Chymotryptic =Two pmoles of fragment C were subjected to each enzymatic digestion. bThe amino acid compositions are based on 24 h hydrolysis values only. CB denotes high voltage paper electrophoresis at pH 6.5 and D denotes dDeterminated as homoserine eAll sequence determinations were carried out with the manual dansyl-Edman paper chromatography. technique. Except for peptide C2 ( 5 0 nanornoles) 120 nanomoles of each pep- tide were subjected to manual deRradation. 128 as shown by SDS-polyacrylamide gel electrophoresis, and charge, as evidenced by ion-exchange chromatography, were obtained in excellent yield. Since the properties of the two fragments precluded their separation, intact fragment A1 was succinylated prior to the acid cleavage. The cleavage mixture was added to the automatic sequencer without prior peptide separation. As expected, the only amino acid sequence obtained, was that of the COOH-terminal acid cleavage fragment H-2 (Fig.3,6). This information together with the NH2-terminal auto- matic amino acid sequence analysis of intact fragment A1 gave almost all of the primary structure of A1 (see Fig.6). Fragment A1 was digested with Staphylococcus Aureus protease V8 and the resulting peptide mixture was resolved by gel chromatography on a column of Sephadex G-50 (Fig.8). Two peptides, denoted SA and SB in Fig. 8A were further purified by column electrophoresis (Fig. 8B and C). Amino acid analysis and automatic sequencing o f the two peptides demonstrated that SA represented the NH2-terminal part of A1 (Table 7). The COOH-terminal fragment SB gave clear sequence information in 23 out of its 24 positions (Table 7). However, this information did not establish a connection between the NH2-terminal region of fragment A1 and the COOH-terminal acid cleavage fragment H-" (see Fig. 6 and Fig. 3.) To obtain further amino acid sequence information about CnBr-fragment Al, this fragment was separately digested with chymotrypsin, thermolysin, pepsin and subtilisin. All digests were subjected to ion-exchange chromatography (Fig. 9). Table 8 summarizes the amino acid compositions and sequences of the isolated peptides. Fragment A1 was also digested with clostripain and the digest was fractionated on a Sephadex G - 5 0 column (Fig. lo). Fraction I con- tained aggregated material and fraction VI contained a single peptide. All other fractions were further purified by DUE-Sepharose ion-exchange chromato- graphy (Fig. 10). A total of twelve clostripain peptides were recovered and they made up the entire A 1 fragment (Table 9). It should be noted that pep- tides ACl I1 1 and ACl I11 1 were identical and that peptides AC1 I1 4, AC1 IV 1, AC1 IV 2 and AC1 IV 3 probably arose by thermolysin-like activity present in the clostripain preparation (see Table 9). The peptides obtained from the various digests (Table 8 and 9) together with the tryptic peptides R1 and R2 (Table 3) gave the entire sequence of CNBr-fragment Al. The gap between the NH2-terminal amino acid sequence (residues 89-136) and the sequence of the acid cleavage fragment H-2 (residues 141-175) was bridged by clostripain peptide AC1 I1 2 (table 91, the chymotryptic peptide AC4 (Table 8) and the thermolysin peptide AT2 (Table 8). To firmly establish the sequence of peptide 129 AC1 I1 2 it was subjected to carboxpeptidase digestion (Fig. 6) in addition to NH2-terminal sequencing. Thus, the information obtained was sufficient .to establish the primary structure of CNBr-fragment Al. Table 7A. Amino acid composition of two Staphylococcus Aureus protease V8 peptides derived from CNBr-fragment Ala*b SA residue 89-158 SB residue 159-182 Amino acid Found To nea- Se- Found To nea- Se- rest quen- rest quen- inte- cec inte- cec aer ger mole/ mole/ Lysine 2.8 3 Histidine 1.0 1 Arginine 3.6 4 CM-Cysteine 2.4 2 Threonined 3 . 3 3 Serined 4.7 5 Glumatic Acid 8.1 8 Proline 2.9 3 Glycine 4.0 4 Alanine 3.9 4 VaIinee 4.6 5 Methionine Isoleucinee 1.6 2 Leucine 5.2 5 Tyrosine 4.8 5 Phenylalanine 3.0 3 Tryptophan 1.7 2 Aspartic Acid 10.6 11 3 1 4 2 11 3 5 8 3 4 4 2 5 5 3 2 0 . 3 0.9 1 3.6 4 2.0 2 2.8 3 1.1 1 2.3 2 1.9 2 1.2 1 5 0.9 0.7 1 3.8 4 1.7 2 1 4 2 3 1 2 2 1 1 1 4 2 Yield 76% 48% aTwo pmoles of CNBr-fragment A1 were digested with the enzyme. bExcept where noted all values are average values of one 24 h and one 72 h CObtained from the sequence shown in Fig. 6. dValues obtained by extrapolation to 0 h hydrolysis. e72 h hydrolysis value hydrolysis. Table 7B. Amino acid sequence analyses of Staphylococcus Aureus protease V8 peptides obtained from CNBr-fragment Ala Peptide Designation Amino Acid Sequence SA Lys-Tyr-Trp-Gly-Val-Ala-Ser-Phe-Leu-Gln-Lys-Gly- -Am-Asp-Asp-His-Trp-Ile-Val-Asp-Thr-Asp-Tyr- SB -Leu-CMCys-Leu-Ala-Arg-Gln-Tyr-Arg-Leu-Ile-Val- -His-Asn-Gly-Tyr-CMCys-Asp-Gly-Arg-Ser-Glu-Arg- - A m - 'Both peptides were degraded in the automatic liquid phase sequencer. The overall repetitive yield was 89% for peptide SA and 91% for peptide SB. In each case 210 nanomoles were subjected to analysis. 130 S A - A 100 200 EFFLUENT VOLUME I ml ) EFFLUENT VOLUME (ml) Fig.8. Purification of Staphylococcus aureus, protease V8 peptides obtained from digestion of 2 pmoles -of CNBr-fragment Al. The digest was applied onto a Sephadex G-50 column (110x2 cm) equilibrated with 0.025% ammonia - 10% propa- no1 ( A ) . Fractions of 2 . 0 ml were collected at 9-min intervals. The denote materials (SA and SB) which were further purified by column electro- phoresis at pH 1 . 9 (B and C). After completed electrophoretic separation the columns were eluted at a flow rate of 1 2 ml/hour. Fractions of 1 . 0 ml were collected. The occurrence of peptides in the effluent was monitored by measur- ing the absorbance at 280 nm. In addition 25 pl-aliquots from each fraction were subjected to alkaline hydrolysis and the ninhydrin reaction. The color developed was measured at 570 nm. Fractions indicated by the bars were pooled and lyophilized. Fig. 9. Ion exchange chromatography on a A 1 polystyrene resin (Jeol AR-15) of peptides derived from CNBr- fragment A1 after digestion with with chymotrypsin ( A ) , thermoly- sin (D). The digests represent- ing 0.8 pmoles ( A and 2) and 1 . 3 pmoles (g and C ) of fragment A1 column. Fractions of 3.0 ml of 3 . 0 ml were collected at a flow rate of 110 ml/h. The bars ( 2 denote highly purified peptides used in subsequent analyses (see Table VIII). Further experimen- 1 tal details are given under FRACTION NUMBER Methods. The ninhydrin color at 570 nm is expressed in arbitrary units (a.u. ). I A C 5 sin (B), pepsin ( C ) and subtili- were separately applied onto the i _- D 9-878572 1 3 1 - T E c 2 2.0 2 hl Lu 0 z < 1.0- m a 0 4 % 132 - I I I I c m - 100 200 Table 8. Amino acid compositiona and amino acid sequenceb of some chymo- tryptic, thermolytic, peptic and subtilisin peptides derived from CNBr-fragment A1 Peptide Des igna- t ion Amino Acid Composition Yield' Residue A_. Chymo trypt icd AC 1 AC2 AC3 AC4 AC5 Thermolytic AT 1 AT2 AT3 AT4 AT5 AT6 AT7 Peptice AP1 AP2 AP3 AP4 AP5 AP6 Subtilisind AS 1 AS 2 AS 3 moles % cl.O D2.7 T0.8 s0.9 G1.O A0.6 L0.9 '0.8 190 24 D1.7 T1.l '0.3 '0.3 '1.0 400 50 90 11 210 26 D0.3 sl.O E0.3 G1.l A1.l '0.9 F 1 . O R0.9 D2.2 s0.9 E1.O p2.9 G1.l A0.8 L1.O R1.O E1.l A0.9 y1.0 220 28 660 51 l4 150 12 600 46 530 41 320 25 330 25 D3.0 T2.1 s0.3 A0.8 v0.6 I0.4 LO.l '1.8 K 1 . O R1.l D2.4 sl.l E2.2 '2.8 G1.3 A1.l L1.l 180 R1.O c0.9 sl.l E1.3 v0.9 L1.O '0.9 R2.0 E4.2 v0.4 I0.4 K0.8 G1.O yl.O R1.l E1.2 A0.9 L1.0 R1.0 L1 .o Y o . 9 cl.l D2.2 T1.2 s0.9 G1.O A1.O ' 0 . 3 D0.3 E1.2 A0.9 vl.O '2.0 K 1 . O H0.9 D3.0 E1.l G1.O L1.l K1.O s0.9 E0.3 G1.O A0.9 "1.1 '1.0 R1.O E1.2 A0.9 R1.l L1.0 '0.9 D2.0 T0.9 G0.9 Lo.9 co.9 A1.1 L2.0 v1.0 F1.O 680 52 220 17 420 32 710 55 340 26 730 56 370 46 80 10 90 11 124-133 106-111 92-96 138-148 162-165 106-115 138 - 150 116-122 161-164 151-158 165-167 89-92 126-133 114-118 97-104 162-164 89-95 165-167 124-128 159-162 136-137 Amino Acid Sequence B. Chymotryptic AC 1 Asx-Leu-Asx-Gly-Thr-CMCys-Ala-Asx-Ser-Tyr AC2 AC 3 Gly-Val-Ala-Ser-Phe AC4 Ser-Arg-Asx-Pro-Asx-Gly-Leu-Pro-Pro- AC5 Ala-Arg-Glx-Tyr Thermolytic AT1 Ile-Val-Asx-Thr-Asx-Tyr-Asx-Thr-Tyr- AT2 Ser-Arg-Asx-Pro-Asx-Gly-Leu-Pro-Pro-Glx-Ala- AT3 Val-Glx-Tyr-Ser-CMCys-Arg-Leu AT4 Leu-Ala-Arg-Glx AT5 Ile-Val-Arg-Glx-Arg-Glx-Glx-Glx AT6 Tyr-Arg-Leu AT7 Lys-Tyr-(-)-Gly I le -Val - Asx-Thr -Asx-Tyr Peptic AP1 Asx-Gly-Thr-CMCys-Ala-Asx-Ser- AP2 Tyr-Ala-Val-Glx-Tyr AP3 Leu-Glx-Lys-Gly-Asx-Asx-Asx-His AP4 Ala-Arg-Glx AP5 Lys-Tyr-(-)-Gly-Val-Ala-Ser AP6 Tyr-Arg-Leu Subtilisin AS 1 Asx-Leu-Asx-Gly-Thr AS2 Leu-CMCys-Leu-Ala AS3 Val-Phe 133 aAll analyses are 24 h hydrolysis values. bAll sequence analyses were carried out by the manual dansyl-Edrnan technique. CYields are not corrected for material taken for analyses during the course of dThe enzymatic digestions were carried out on 0.8 gmoles of fragment Al. eThe enzymatic digestion was carried out on 1.3 moles of fragment Al. the purification procedure. Table 9. Amino acid compositiona and amino acid sequenceb of clostripain peptides obtained after digestion of 0.75 gmole of [ I4C] carboxy- methylated CNBr-fragment A1 Peptide Yield Residue Desig- Amino Acid Composition nmoles % nation A. 250 33 140-153 A 'I1 A c1 112 R1.3 c1.2 D3.1 T1.O s2.9 G1.l A1.4 '1.0 L2.2 '1.0 F2.0 240 150 2o 32 122-139 122-134 80 11 106-115 A c1 113 A c1 114 A c1 1111 K1.3 R1.O D2.1 '0.4 E2.2 p3.0 G1.4 A1.3 '0.9 I0.7 L1.2 230 8o 31 l1 154-163 140-153 A c1 1112 R2.0 cl.l D0.4 E4.0 G0.3 A1.2 '0.3 L2.3 280 37 167-177 A c1 1113 H0.8 R1.O c1.2 D2.0 E0.4 G1.7 '0.7 I0.5 L1.l '0.8 70 9 178-180 60 8 181-182 A c1 IV1 A C1 IV2 D1.0 L0.g 300 40 116-121 A c1 IV3 340 45 164-166 A c1 v1 A c1 vll 530 71 89-105 K1.l R1.O D2.2 E2.1 p3.1 G1.2 A1.l v0.7 '0.5 L1.O c1.3 D3.0 T1.O '2.0 G1.l A1.O L3.0 '1.0 D3.0 T1.6 A1.O '0.8 I0.5 L0.2 '1.7 R 1 . 0 Sl.1 E1.2 R1.O E1.2 '1.0 R1.O c1.2 s1.0 E1.2 v1.0 y1.0 K1.9 H0.8 D3.0 '0.9 E1.2 G2.1 A1.O v0.9 L1.O y0.9 F 1 . O Amino acid sequence B. ii c1 I11 A C1 I12 A C1 I13 A C1 I14 A C1 1111 A C1 1112 A C1 1113 A C1 IV1 A C1 IV2 A C1 IV3 A C1 V1 Asp-Pro-Asn-Gly-Leu-Pro-Pro-Glu-Ala-Gln-Lys-Ile- Leu-Leu-Asn-Leu-Asp-Gly-Thr-CMCys-Ala-Asp-Ser-Tyr-Ser-Phe-Val-Phe-Ser Leu-Leu-Asn-Leu-Asp-Gly-Thr-CMCys-Ala-Asp-Ser-Tyr- Ile-Val-Asp-Thr-Asp-Tyr-Asp-Thr-Tyr-Ala Asp-Pro-Asn-Gly-Leu-Pro-Pro-Gln-Ala-Gln-Lys-Ile-Val- Gln-Arg-Gln-Glu-Glu-Leu-CMCys-Leu-Ala-Arg Leu-Ile-Val-His-Asn-Gly-Tyr-CMCys-Asp- Ser-Glx-Arg Asx-Leu Val-Glx-Tyr-Ser-CMCys-Arg Glx-Tvr-Ara -Arg- A C1 VI1 Lys-T;r-Trp-Gly-Val-Ala-Ser-Phe-Leu-Gln-Lys-Gl~-Asn-Asp-As~- aAll analyses are 24 h hydrolysis values. bThe peptides designated A C1 11, A C1 I11 and A C1 VI were all subjected to automatic sequence analysis in the liquid phase sequencer. Between 50 to 110 nanomoles of peptide were used in these analyses. The repetitive yield varied between 91 and 94%. Peptides designated A C1 IV and A C1 V were degraded manu- ally with use of the dansyl-Edman technique. Between 30 and 70 nanomoles of peptide were used. fication procedure. CYields have not been corrected for material taken for analyses during the puri- The COOH-Terminal Amino Acid Sequence of RBP - We have previously suggested that the COOH-terminus of RBP is involved in the regulation of the catabolism of the protein and we obtained data that the COOH-terminal residue of is RBP 134 arginine (43). Other authors have obtained other COOH-terminal sequences for RBP (12,55). It was, therefore, of importance to clarify this discrepancy. Fig. 6 shows that amino acid sequence determinations of peptides SB (Table 7) and AC1 IV 1 (Table 9) provided the sequence Arg-Asn-Leu. To corroborate this information, intact, reduced and carboxmethylated RBP as well as CNBr-fragment A1 and peptide SB were separately subjected to carboxypeptidase A and B diges- tions. Fig. 11 summarizes the results obtained with fragments A1 and peptide SB. Both types of materials clearly showed that the COOH-terminal sequence is Asn-Leu. The digestions of peptide SB also provided strong support for the established sequence (Fig.61, k. that arginine preceeds the asparagine. The arginine was not as evident when carboxypeptidase B digestions of fragment A1 (Fig.llA) and intact RBP (not shown) were carried out. The reason for this was that several amino acid residues were released almost simultaneously on the addition of carboxypeptidase B. However, the carboxypeptidase digestions together with the amino acid sequence information summarized in Fig.6 establish the COOH-terminal sequence of RBP. 20 LO 60 INCUBATION TIME ( m i n ) Fig.11. Carboxypeptidase digestions of CNBr-frag- ment A1 ( A ) and Staphylococcus aureus protease V8 peptide SB (g) . The samples, each comprising 50 nanomoles of peptide were mixed with carboxypeptidase A (40ug).After 30 min of incubation carboxypeptidase B (25pg) was added (arrow). Samples were withdrawn at the indicated times and amino acids released were identified and quantitated by amino acid analysis. The values given in the figure have been corrected for the presence of free amino acids in the carboxypeptidase preparations and in the peptide fractions. The symbols in the figure are : 0---0, leucine;-, asparagine;c- --a, arginine; o - - - o , alanine w, tyrosine. Localization of Disulfide Bridges in RBP - Intact RBP was subjected to acid Cleavage and gel chromatography on a column of Sephadex G-100. Fig. 12 depicts the chromatogram. Fraction SI was subjected to amino acid analysis and NH2- terminal amino acid sequence determination (Table 10) which clearly showed that SI corresponds to residues 8 3 to 140 (Fig.6.). Thus, half-cystines 120 and 129 must form a disulfide bridge as RBP does not contain any free sulfhyd- ryl groups. 135 E w2.0- e 0 EFFLUENT VOLUME ( m l Fig. 12 Gel chromatography of 3 pmoles of acid-cleavaged RBP on a column (16Ox2cm) of Sephadex G-100 equilibrated with 0.05 M sodium acetate, pH 5.0, containing 6M guanidine-HC1. The acid cleavage was obtained by incubating the protein in 70% (v/v) formic acid at 37' for 24 h. After this period of time the formic acid was diluted with H20 and the protein was lyophilized. The column had a flow rate of 3.4 ml/h and fractions of 2.0 ml were collected. Material denoted by the bar was pooled, dialyzed and lyophilized. Table 10 A . Amino acid composition of acid cleavage fragment SI derived from intact R B P ~ . ~ Amino acid SI residue 83-140 Found To nearest integer Sequence' Lysine Histidine Arginine CM-cysteined Aspartic acid Threoninee Serinee Glutamic acid Proline Glycine Alanine Valinef Methionine Isoleuc inef Leucine Tyrosine Phenylalanine Tryptophan 3 . 7 1.0 2.0 2.1 9.6 3 . 1 4.7 2 . 3 1 . 3 3 . 2 4 . 0 3.8 1.0 1.1 4 . 3 5.1 4.0 1.9 moleimole 4 1 2 2 10 3 5 2 1 3 4 4 1 1 4 5 4 2 4 1 2 2 10 3 5 2 1 3 4 4 1 1 4 5 4 2 Yield 27% aThree vmoles of RBP were subjected to acid cleavage. bExcept where noted all values are average values of one 24 h and one 72 h 'Calculated from the sequence shown in Fig.6 (residues 8 3 - 1 4 0 ) . dThe acid cleavage fragment was reduced and carboxymethylated after the gel '=Values obtained by extrapolation to 0 h hydrolysis. f72 h hydrolysis value. Table 10 B. Amino acid sequence analysis of acid cleavage fragment SIa Pro-Ala-Lys-Phe-Lys-Met-Lys-Tyr-Trp-Gly-Val-Ala-Ser-Phe-Leu-Gln- Lys-Gly-Asn-Asp-Asp-His-Trp-Ile-Val-Asp-Thr-Asp-Tyr-Asp-Thr-Tyr- Ala-Val-Gln-Tyr-Ser-CMCys-Arg-Leu-Leu-Asn- aDegradation was accomplished on 190 nanomoles of peptide in the automatic hydrolysis. chromatography separation (see Fig.12). sequencer. The repetitive yield was 93%. 136 Material corresponding to fraction A of Fig. 1A which comprised the half- cystine-containing CNBr-fragments of RBP, was separately subjected to trypsin digestion at pH 6.0 and pepsin digestion at pH 5.0. The digests were separate- ly subjected to Sephadex G-50 gel chromatography in dilute acetic acid (Fig.13). Fractions denoted T and P in Fig. 13 contained half-cystine as monitored by amino acid analysis. These two fractions were pooled and lyophi- lized. Fraction T was further purified by column electrophoresis (Fig.14) and the pooled fraction T1 was subjected to performic acid oxidation and re- electrophoresed (Fig. 14) to yield peptides T1A and T1B. Both the amino acid composition and the sequence establish that peptide T1A corresponds to residues 167 to 177 and T1B to residues 63 to 73 of RBP (Table 11 and Fig. 6).Thus, the half-cystines in positions 70 and 174 of RBP form a disulfide bridge. Fraction P Fig. 13 was further purified by column electrophoresis (Fig. 14). Both peptide P1 and P2 contained half-cystine. After performic acid oxidation and re-electrophoresis peptide P1 appeared as a single homogenous peak (not shown). Amino acid analysis and sequence determination (Table 11) demonstrated that peptide P1 corresponded to residues 118 to 135, which corroborates the previously established disulfide bond between half- cystines 120 and 129 ( s e e above). Peptide P2 was further purified by high pressure liquid chromtography (Fig. 15) to yield fraction P2A. After performic acid oxidation this material was re-subjected to high pressure liquid chromatography. Fig. 15B demonstrates that three peptides, P2A1, P2A2 and P2A3, could be isolated. Table 11 ascer- tains that P2A1 and P2A2 represent residues 1 to 9 of RBP and that P2A3 corre- sponds to residues 159 to 161. Thus, the third disulfide bond engages the half-cystines in positions 4 and 160. The complete amino acid sequence of human RBP, including the disulfide bridges, is depicted in Fig. 16. DISCUSSION Prior t o the analysis of the RBP sequence reported here, two laboratories presented partial NH2-terminal sequence information (27,38). Their information is in full agreement with the sequence elucidated here. After completion of this study Kanda and Goodman (21) reported the primary structure for the NH2- terminal 121 positions of human RBP. Although their data are generally in good agreement with those described here, some noteable differences occur in posi- tions 50 to 53 (our numbering), 58 to 60, 111 to 114 and 119 to 120. In most of these positions Kanda and Goodman assigned amino acid residues from data obtained by COOH-terminal digestions or from the amino acid composition of 137 Fig.13. Gel chromatography of trypsin (4) and pepsin ( g ) digested disulfide-linked CNBr-fragments Al,A2, A3a and A3b (cf. fraction A of Fig.lA) on a column (100x2 cm) of Sephadex G - 5 0 equili- brated with 10% (v/v) acetic acid. Five pmoles of RBP cleaved with CNBr were subjected to gel chromatography as described in the legend of Fig.lA. Material corresponding to fraction A of Fig.lA was pooled, desalted, lyophilized and divided into two equal parts. One part was dissolved in 4 ml of Tris-acetate buffer, pH 6.0, and the other part was dissolved in 4 ml of 0 . 2 M sodium acetate buffer, pH 5 . 0 . Each enzyme (0.8 mg) was added to one aliquot and the digestions were allowed to proceed for 8 hours at 3 7 O . The samples were then immediately applied onto the columns, which were eluted at a flow rate of 6.0 ml/hour. Fractions of 2 . 0 ml were collected. Aliquots (50 p1) from every third fraction were subjected to amino acid analysis. Fractions denoted by the bars contained cysteine and accordingly were pooled and lyophilized. Fig. 1 4 . Fraction T of Fig. 13A was subjected to elec- trophoresis on a column of cellulose at pH 1.9 (&).Fractions denoted T1 in &, which contained cysteine as monitored by amino acid analyses on aliquots from alternate fractions, were pooled, lyophilized, subjected to performic acid oxida- tion and re-electrophoresed under identical conditions ( g ) . Fractions denoted by the bars were pooled and lyophilized. Material in frac- tion P of Fig. 12B was also subjected to elec- trophoresis at pH 1.9 ( C ) . Material denoted by the bars contained cysteine as revealed by amino acid analysis performed on aliquots withdrawn from every second fraction. Conse- quently, those fractions were pooled and lyo- philized. The experimental details were the same as in Fig. 8B and C. I ‘2 Fig.15. (next page) High pressure liquid chromatography of the material designated P2 in Fig.14C ( A ) . The c18 reversed phase column was equilibrated with 2 mM ammonia, adjusted to pH 2.4 with trifluoroacetic acid, and 5% methanol. The applied material was eluted with an 80-ml linear gradient of methanol from 5 to 55% followed by 30 ml of 55% methanol. The flow rate of the column was 24 ml/h and fractions were collected at 1 min intervals. All absorbance peaks were separately pooled and aliquots from each were subjected to amino acid analysis. Only the fraction denoted P2A contained significant amounts of cysteine. Therefore, this fraction was subjected to performic acid oxidation and re-chromatographed on the C 18 column (g) under conditions identical to those described above. Fractions denoted by the bars were pooled and lyophilized. 138 a3 0.2 E 2 W 0.1 W 0 z 4 m m m SI a OF .l 0.04 Fig.lS. A _ - P2 A B P2AA P2A3 P2 x 2 I 1 100 2 00 RETENTION TIME (rnin) 0 O W ul < r o n u a s z 4 0 0 3 I I Fig.16. The complete amino acid sequence of human RBP depicting the distribution of the three disulfide bonds. 139 Table 11. Amino acid compositiona and amino acid sequenceb of tryptic and Peptide Desig- Amino acid composition nation Yield' Residue peptic cysteine-containing RBP peptides A. Tr yp t ic nmoles % H1.O R1.3 D5.6 M0.6dG2.1 A1.2 '1.1 '1.8 I 0 . 8 L2.3 yl.O 520 H1.2 R1.2 '1.1 D2.3 G2.2 '0.9 '0.9 L0.8 ' 0 . 8 250 10 167-177 '1.0fD4.0 M0.7dAl.2 '1.0 L2.2 350 14 63- 73 Peptic p1 R1.O C1.8fD2.9 T1.O '2.9 G1.l A1.O L3.0 y1.5 F0.7 390 16 118-135 p2 R2.1 C1.ZeD1.2 s1.9 E1.0 v1.0 L2.2 F1.l 440 18 P2A1 R1.9 Cl.OfD1.O s1.8 E0.9 vl.l F0.7 150 6 1-9 P2A2 R2.1 C0.9fDl.l s2.0 .O '1. 1 F0.6 130 5 1-9 P2A3 '1.0 L1.9 200 8 159-161 21 Amino acid Sequence B. F1A Leu-Ile-Val-His-Asn-Gly-Tyr-Tyr-CysA-Asp-Gly- T1B Leu-Leu-Asn-Asn-Trp-Asp-Val-CysA-Ala- P1 Tyr-Ser-CysA-Arg-Leu-Leu-Asn-Leu-Asp-Gly-Thr-CysA-Ala-Asp-Ser- P2A1 Glu-Arg-Asp-CysA-Arg-Val-Ser- P2A2 Glu-Arg-Asp-CysA-Arg-Val- P2A3 Leu-CysA-Leu aAll analyses are 24 h hydrolysis values. Tryptophan was not determined. bAll peptides except P2A3 were degraded in the automatic sequencer. Peptide P2A3 was analyzed by the manual dansyl-Edman method. Between 70 and 160 nano- moles of each peptide were subjected to the automatic sequencer. The repetitive yield varied between 87 and 94% for the different peptides. Of peptide P2A3 50 nanomoles were used for the amino acid sequence determination. 'Yields were not corrected for material taken for analyses during the isolation procedure. dDetermined as homoser ine eDetermined as cysteine fDetermined as cysteic acid after performic acid oxidation peptides. In contrast, these positions are in our sequence analyzed by NH2- terminal degradation of several peptides. In all other positions identical residues were found although Kanda and Goodman could not unequivocally assign amides and acids in few positions. The sequence of human RBP predicted from a cDNA clone (5) agrees completely with the one described here, except in the COOH-terminus (see below). The COOH-terminus of RBP has received particular attention in as much as two forms of RBP exist physiologically (34). They differ in their ability to interact with prealbumin. The non-bound form contains very little retinol, has a changed conformation (42) and is more acidic than the prealbumin-binding species (43). We previously reported that the more acidic form lacked arginine in its COOH-terminus (43). This erroneous information, which was obtained by carboxypeptidase B digestion, probably arose from the occurrence of trypsin- like activity present in the carboxypeptidase preparation. Two other laborato- 140 ries have also attempted to establish the COOH-terminal sequence of human RBP (12,55). In both cases data were obtained which do not agree with the present results. However, in the present study the COOH-terminal sequence was estab- lished not only by carboxypeptidase digestions but also by NH2-terminal se- quencing of peptidose whose amino acid compositions corroborated the results obtained. Nevertheless, the amino acid sequence predicted from a cDNA clone encoding human RBP is one residue longer in the COOH-terminus than the determined protein sequence (5). Analysis of a cDNA clone for rat RBP also predicted an additional amino acid residue compared to the determined protein sequence of human and rabbit RBP (51). Neither the data on the rabbit nor on the human sequence support the presence of an additional residue of leucine as the COOH- terminus, although admittedly it is difficult with available sequencing tech- niques to distinguish the sequence -Am-Leu-COOH from Asn-Leu-Leu. However, since the COOH-terminus of RBP is located at the surface and seems to be quite flexible (30), it is possible that the additional COOH-terminal leucine resi- due encoded by the RBP gene might be removed in a post-translation event. The amino acid sequence of RBP was subjected to a computer search to inves- tigate whether any of the previously sequenced proteins would display any structural homology to RBP (6,9). Three proteins, P-lactoglobulin (3), human al-microglobulin (11,25) and rat a2-microglobulin ( 5 4 ) were found. The se- quences of these proteins, which are of similar sizes, were aligned to that of human RBP by the computer program ALIGN (29). The alignment scores are shown in Table 12. As all values above 3 are regarded as significant this analysis clearly shows that all four protein sequences are related to each The same conclusion has been reached by two other laboratories (15,32). A closer l o o k at the aligned sequences (Fig.17) shows that in eight instances only one type of amino acid residue occupies the same position in all four sequences. In another 20 positions only two alternative amino acids exist. It can accord- ingly be inferred that the four proteins belong to the same protein super- family. other. Three of the four proteins, RBP (28,36), the rodent a2-microglobulin ( 4 4 1 , and most probably human al-microglobulin (1) are produced in liver cells. Rodent a2-microglobulin and, to a certain extent, RBP are under androgen control (10,45,49). The same might also hold true for human al-microglobulin (53). The synthesis of RBP and of rodent a2-microglobulin is also influenced by glucocorticoids (2,4). Whether any physiological similarities exist between these three liver-produced proteins remains to be established as the molecular functions of rodent a2-microglobulin and of human al-microglobulin are still unknown. 141 Table 12. Alignment scores for comparisons of human RBP with bovine p- lactoglobulin, human al-microglobulin and rat a2-microglobulin Bovine Human a1 Rat a2- 0-lacto- micro- micro- globulin globulin globulin Human RBP (1-182) 5.97 8.21 5.18 Bovine 0-lactoglobulin (1-162) 7.53 10.69 Human al-microglobulin The alignment scores, which were obtained with the use of the program ALIGN, represent the number of standard deviations of the real score above the ran- dom score. Numbers in parentheses: residue numbers compared. The sequnces of bovine B-lactoglobulin, human were taken from ref. 3. 25 and 54, respectively. (1-167) 9.35 al-microglobulin, and rat a2-microglobulin 0 0 . 0 b ! 1 0 R6P 0 : . .. !.!* t t o 0 1 2 0 1 4 " Fig.17. Comparison of the amino acid sequence of human RBP with the sequence of bovine 0-lactoglobulin (3), human al-microglobulin (1,441, and rat a2-microglobulin (45). The alignment was obtained by maximizing the homology using the computer program ALIGN. Boxes: residues shared by the RBP sequence and any of the other sequences. Arrows: positions with a single amino acid residue shared by all the four proteins. Stars: positions with two amino acidresidue alternatives for the four sequences. Bovine p-lactoglobulin has been reported to bind retinol in a similar way to RBP (14). Indeed, B-lactoglobulin has been suggested to function in binding, protecting and facilitating the uptake of retinol in the intestine of suckling young animals (16,32). The four proteins of the RBP superfamily might also have similar tertiary structures. Disulfide bonds homologous to that between 142 residues 7 5 and 1 8 0 in RBP are also found in 8-lactoglobulin ( 2 6 ) and in human a-microglobulin ( 4 4 ) and a disulfide bound homologous to that between residues 125 and 1 3 4 in RBP is present in 0-lactoglobulin. Moreover, recently the three-dimensional structures of both RBP ( 3 0 ) and 0-lactoglobulin ( 4 6 ) were reported. The polypeptides folds of the two proteins are remarkably similar. The computer analyses suggested that RBP might have arisen by an internal duplication of its primordial gene. Residues 3 6 - 8 3 and 9 6 - 1 4 1 of human RBP display statistically significant homology ( 6 ) . A similar internal homology has been noted in P-lactoglobulin ( 2 2 ) . This internal homology would suggest that the primordial gene for RBP once coded for a protein with a molecular weight of about 1 4 , 0 0 0 . This is the I molecular weight of the intracellular Retinol-binding protein (31) but the amino acid sequence of that protein is not homologous t o that of serum RBP (39,501. However, piscine serum RBP which does not bind to prealbumin has a molecular weight of about 16,000 ( 4 7 ) and therefore the possibility was raised that the gene for serum RBP underwent a partial duplication after the divergence of fish and mammals. The three-dimen- sional structure of RBP is also consistent with a partial duplication event. However, the retinol binding site is formed by side-chains from both putative duplicated portions (30). It is therefore probable that the two 'homologous portions found in mammalian RBP also are present in piscine RBP, assuming that the site for retinol has been conserved. Moreover, the exon-intron organization and the nucleotide sequence of the rat RBP gene ( 2 4 ) did not show any obvious similarities between the portions of the gene encoding residues 3 6 - 8 3 and 9 6 - 1 4 1 . These data together with the similarities in three-dimensional structure between RBP and P-lactoglobulin suggest that if a partial duplication has been involved in the evolution of RBP, it occurred before the divergence of RBP from P-lactoglobulin and the other proteins in the RBP superfamily. ACKNOWLEDGEMENTS Expert technical assistance was provided by Mr Kjell Andersson, Mr Jorgen Ericson, Ms Inga Sjoquist and Ms Yvonne Tillman. The computer analyses were kindly carried out by Ms Elisabetta Rossi. Some of the urinary RBP used in these analyses was a gift from the late Dr Ingemar Berggird and his col- leagues. The constant support and advice provided by Dr Hans Bennich proved invaluable. The patient typing of this manuscript could only have been accom- plished by Ms Anna-Greta Lundquist and Ms Margareta Moliteus. This work was supported by grants from the Swedish Medical Research Council. 143 REFERENCES 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21. Berggird,B., Ekstrom,B., & Bkerstrom,B. :al-microglobulin. Scand.J.Clfn. Lab.Invest.40:Suppl.154,63-71,1980. Borek, C., Smith,J.E., Sopran0,D.R. & Goodman, D.S.: Regulation of Retinol-binding protein metabolism by glucocorticoid hormones in cultured HhIIEC3 liver cells. Endocrinology 109:386-391, 1981. Braunitzer,G., Chen,R., Schrank,B. & Stang1,A.: Die Sequenzanalyse des 0- Lactoglobulins. Hoppe-Seyler's Z. Physiol.Chem. 354:867-878, 1973. Chen,C.-L.C. & Feigelson,P.: Hormonal induction of a2p-globulin synthesis in isolated rat hepatocytes. Biochemistry 17: 5308-5313, 1978. Colantuoni,V., Romano,V., Santoro,C., Costanzo,F., Raugei,G., and Cortese,R.: Cloning and sequencing of a full length cDNA for human retinol-binding protein . Nucleic Acids Res.l1:7769-7776,1983. Dayhoff, M.O.: Atlas of protein sequence and structure. (National Biomedical Research Foundation, Washington D.C. ,USA) 5,1972. Dayhoff,M.O.: Atlas of protein sequence and structure. (National Biomedical Research Foundation, Washington, D.C., USA) 5, suppl. 1973. Dayhoff,M.O.:Atlas of protein sequence and structure.(National Biochemical Research Foundation, WashingtonD.C.,USA) 5, suppl.2, 1976. Dayhoff,M.O.: Atlas of protein sequence and structure. (National Biomedical Research Foundation, Washington, D.C.,USA) 5 , suppl.3, 1978. Eklund,A. & Rask,L.: Zinc status and serum levels of retinol-binding protein, tocopherol and lower density lipoproteins in male and female rats fed on semi-purified diets containing rapeseed protein o r casein. Nutr.Metab.23:458-466, 1979. Ekstrom,B.,Peterson, P.A., & Bergg&d,I.: A urinary and plasma al- glycoprotein of low molecular weight: isolation and some properties. Biochem.Biophys.Res.Commun.,65: 1427-1433, 1975. Fex,G. & Hansson,B.: Retinol-binding protein from human urine and its interaction with retinol and prealbumin. Fohlman,J., Eaker,D., Karlsson,E. & Thesleff,S.: Taipoxin, an extremely potent presynaptic neurotoxin from the venom of the Australian snake taipan (Oxyuranus s . scutellatus). Eur.J.Biochem.68: 457-469,1976. Fugate,R.D. & Song,P-S.: Spectroscopic characterization of p- lactoglobulin-retinol complex. Biochim.Biophys.Acta 625:28-42,1980. Godovac-Zimmerman,J., Conti,A., Liberatori.J., & Braunitzer,G.: Homology between the primary structure of 0-lactoglobulins and human retinol- binding protein: evidence for a similar biological function. Biol.Chem. Hoppe-Seyler 366:431-434,1985. Godovac-Zimmermann,J., Conti,A., Liberatori,J., & Braunitzer,G.: The amino-acid sequence of B-lactoglobulin I1 from horse colostrum (Equus caballus Perissodactyla): P-lactoglobulins are retinol-binding proteins. Biol.Chem.Hoppe-Seyler 366: 601-608, 1985. Gray,W.R.: Sequence analysis with dansyl chloride. in Methods of Enzymology 25 (ed.C.W. Hirs & S.N. Timasheff)p.p. 333-344. Academic Press N.Y., 1972. Hartley,R.W.: Peptide analysis and preparation with an amino acid analyzer. Anal.Biochem.46: 676-680, 1972. Heller,J.: Interaction of plasma retinol-binding protein with its receptor. J.Biol.Chem.250: 3613-3619, 1975. Kanai,M., Raz,A., & Goodman,D.S.: Retinol-binding protein: the transport protein for vitamin A in human plasma. J.Clin.Invest 47:2025-2044, 1968. Kanda,Y. & Goodman, D.S.: Partial amino acid sequence of human plasma retinol-binding protein. Isolation and alignment of the five cyanogen bromide fragments and the amino acid sequence of four of the fragments. J.Lipid Res.20: 865-878, 1979. Eur.J.Biochem.94:307-313,1979. 144 22. 23. 24. 25. 26. 27. 28. 29. 30. 31. 32. 33. 34, 35. 36. 37. 38. 39. 40. 41. 42. Kolde,H-J., & Braunitzer, G.: The primary structure of ovine 8 - lactoglobulin 1. Isolation of the peptides and sequence. Milchwissenschaft 38: 18-20, 1983. Landon,M.: Clevage at aspartyl-prolyl bonds. in Methods in Enzymology 47 (ed. C.H.W. Hirs & S.N. Timasheff) pp 145-149, Academic Press N.Y., 1977. Laurent,B.C., Nilsson,M.H.L., BZivik,C.O., Jones,A.T., Sundelin,J., & Peterson,P.A.: Characterization of the Rat Retinol-binding Protein Gene and Its Comparison to the Three-dimensional Structure of the Protein. J.Biol. Chem.260:11476-11480., 1985. Lopez,C., Grubb,A., Soriano,F., & Mendez,E.: The complete amino acid sequence of human complex-forming glycoprotein heterogenous in charge (protein HC). Biochem Biophys.Res.Commun.103:919-925, 1981. McKenzie,H.A., Ralston,G.B., & Show,D.C.: Location of sulfhydryl and disulfide groups in bovine P-lactoglobulins and effect of urea. Biochemistry, 11:4539-4547, 1972. Morgan,F.J., Canfield,R.E., & Goodman,D.S. The partial structure of human plasma prealbumin and retinol-binding protein. Biochim.Biophys.Acta 236:798-801,1971. Muto,Y., Smith,J.E., Milch,P.O., & Goodman,D.S.: Regulation of retinol- binding protein metabolism by vitamin A status in the rat. J.Biol.Chem. 247:2542-2550, 1972. Needleman, S.B., & Wunsch, D.C.: A general method applicable to the search for similarities in the amino acid sequence of two proteins. J.Mol.Bio1. 48:443-453,1970. Newcomer,M., Jones,T.A., Aqvist, J., Sundelin, J . , Eriksson,U., Rask, L., & Peterson,P.A.: The three-dimensional structure of retinol-binding protein. EMBO J. 3:1451-1454, 1984. Ong,D.E., & Chyti1,F.: Cellular retinol-binding protein from rat liver. Purification and characterization. J.Biol.Chem. 253:828-832, 1978. Pervaiz,S. & Brew,K.: Homology of P-lactoglobulin, serum retinol-binding protein, and protein HC. Science 228:335-337,1985. Peters0n.P.A.: Studies on the interaction between prealbumin, retinol- binding protein, and vitamin A. J.Biol.Chem. 246:44-49,1971. Peterson,P.A.: Demonstration in serum of two physiological forms of the human retinol-binding protein. Eur.J.Clin. Invest. 1:437-444,1971. Peterson,P.A. & Berggird,I.: Isolation and properties of a human retinol- transporting protein. J.Biol.Chem. 246:25-33,1971. Peterson,P.A., Rask,L., Ostberg,L., Andersson,L., Kamwendo,F., & Pertoft,H.; Studies on the transport and cellular distribution of vitamin A in normal and vitamin A-deficient rats with special reference to the vitamin A-binding plasma protein. J.Biol.Chem. 248:4009-4022,1973. Porath,J.: Methodological studies of zone-electrophoresis in vertical columns. I. Fractionation in cellulose powder columns of substances of low molecular weight exemplified by amino acids and related compounds. Biochim.Biophys.Acta 22:151-175, 1956. Poulik,M.D., Farrah,D., Malek,G.H., Shinnick,C.J., & Smithies,O.: Low molecular weight urinary proteins. I. Partial amino acid sequences of the retinol-binding proteins of man and dog. Biochim.Biophys.Acta 412:326-334, 1975. Rask,L., Anundi ,H., Bohme, J., Eriksson,U., Ronne,H., Sege,K., & Peterson,P.A. Structural and functional studies of vitamin A-binding proteins. Ann.N.Y.Acad.Sci.359:79-90,1981. Rask.L., Anundi,H., & Peterson,P.A.: The primary structure of the human retinol-binding protein. FEBS Lett. 104:55-58.1979. Rask,L., & Peterson,P.A.: In vitro uptake of vitamin A from the retinol- binding plasma protein to mucosal epithelial cells from the monkey's small intestine. J.Biol.Chem. 6360-6366,1976. Rask,L., Peterson,P.A., & Bjork,I.: Conformational studies of the human vitamin A-transporting protein complex. Biochemistry 11:264-268,1972. 145 43 * 44. 45. 46. 47. 48. 49. 50. 51. 52. 53. 54. 55. 56. Rask,L., Vahlqvist,A., & Peterson,P.A.; Studies on two physiological forms of the human retinol-binding protein differing in vitamin A and arginine content. J.Biol.Chem. 246:6638-6646, 1971. Roy,A.K., & Neuhaus,O.W.: Proof of the hepatic synthesis of a sex- dependent protein in the rat. Roy,A.K., & Neuhaus,O.W.: Identification of rat urinary proteins by zone and immunoelectrophoresis. Proc.Soc.Exp.Biol.Med. 121:894-899,1966. Sawyer,L., Papiz,M.Z., North,A.C.I., & Eliopoules,E.E.:Structure and function of bovine P-lactoglobulin. Biochem.Soc.Trans. 13:265,1985. Shidoji,Y., & Muto,Y.: Vitamin A transport in plasma of the non-mammalian vertebrates:isolation and partial characterization of piscine retinol- binding protein. J.Lipid Res. 18:679-691,1977. Smith,J.E., Borek,C., & Goodman,D.S.: Regulation of retinol-binding protein metabolism in cultured rat liver cell lines. Cell 15:865- 873 , 1978. Smith,F.R., Raz,A., Goodman,D.S.: Radioimunoassay of human plasma retinol binding protein. J.Clin.Invest. 49:1754-1761,1970. Sundelin,J., Anundi,H., TragHrdh,L., Eriksson,U., Lind,P., Ronne,H., Peterson,P.A., & Rask,L.: The primary structure of rat liver cellular retinol-binding protein. J.Biol.Chem. 260:6488-6493,1985. Sundelin,J., Laurent,B.C., Anundi,H., Trag&dh,L., Larhammar,D., Bjorck,L., Eriksson,U., akerstrom,B., Jones ,A. , Newcomer,M. , Peterson,P.A., & Rask,L.: Amino acid sequence homologies between rabbit, rat and human serum retinol-binding proteins. J.Biol.Chem. 260:6472- 6480,1985. Takagi,T., Takagi,K., & Kawai,T.: Complete amino acid sequence of human a,-microglobulin. Biochem.Biophys.Res.Commun. 98:997-1001,1981. Tejler,L.: Protein HC. A low molecular weight plasma protein. Thesis University of Lund, Lund, Sweden, 1978. Unterman,R.D., Lynch,K.R., Nakhasi,H.L., Dolan,K.P., Hamilton,J.W., Cohn,D.V., & Feigelson, P.: Cloning and sequence of several a2p-globulin cDNAs. Proc.Natl.Acad.Sci. USA. 78:3478-3482,1981. White,G.H., Western,S.M., & Glover,J.: Carboxy-terminal sequence of retinol-binding protein from human plasma. FEBS Lett. 27:107-110,1972. Woods,K.R., & Wang,K.T.: Separation of dansyl-amino acids by polyamide layer chromatography. Biochim.Biophys.Acta 133:369-370,1967. Biochem.Biophys.Acta 127:82-87,1966. Address for reprints: Lars Rask Department of Cell Research Uppsala Biomedical Center Box 596 5-751 24 Uppsala, Sweden 3Present address : Department of Infectious Diseases University Hospital S-751 85 Uppsala 2Present address : National Board of Occupational Safety and Health Ekelundsvagen 16 5-171 84 Solna 4Present address : Department of Immunology Research Institute of Scripps Clinic 10666 North Torrey Pines Road LA JOLLA, CA 92037, USA 146